Beyond "Disease X": Strategic R&D in an Era of Emerging Threats

Register here

October 30, 2024 01:00 PM US/Eastern
 

Join Biosynth for their fascinating webinar on emerging infectious diseases, like COVID-19 and Ebola which pose an ever-present threat to global health. The World Health Organization's R&D Blueprint is a crucial tool in this ongoing battle, prioritizing research and development for pathogens with the highest potential to cause widespread epidemics. However, limited resources and the specter of unknown "Disease X" threats underscore the urgency and complexity of this task.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

I have read and understand the Privacy Notice*

Subscribe